Among patients with inflammatory bowel disease (IBD), overlapping biologic therapy was common during medication switches and was not associated with a higher risk for infection than nonoverlapping ...
In patients with inflammatory bowel disease (IBD), biologic treatment demonstrated strong 12‑month persistence, with levels of a disease activity marker declining over time. "Taken together, these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results